Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Publications

Berg P, Ruppert-Seipp G, Müller S, Maurer GD, Hartmann J, Holtick U, Buchholz CJ, Funk MB (2025): CAR T-cell-associated secondary malignancies challenge current pharmacovigilance concepts.
EMBO Mol Med 17: 211-218.
Text

Berg P, Schönefeld S, Ruppert-Seipp G, Funk MB (2022): Regulatory Measures to Improve the Safety of CAR-T-Cell Treatment.
Transfus Med Hemother 50: 218-225.
Text

Funk MB, Frech M, Spranger R, Keller-Stanislawski B (2015): Überwachung der Sicherheit von Zelltherapeutika (CBMPs).
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 58: 1239-1246.
Online-Abstract

Updated: 08.01.2025